Unaudited Standalone Financial Results Of The Company Forthe Second Quarter And Half Year Ended 30 September2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Zenith Healthcare reported Q2 FY26 revenue from operations of ₹226.66 lakhs, down from ₹302.79 lakhs in Q2 FY25 — a drop of about 25% year-on-year. Despite the topline decline, net profit for the quarter rose to ₹14.18 lakhs versus ₹9.34 lakhs in the year-ago quarter, helped by lower operating expenses. However, Q1 FY26 had slipped into a small loss of ₹1.88 lakhs, pulling half-year PAT down to around ₹12.30 lakhs. The auditor (Doshi Doshi & Co) issued an unmodified limited review report with no qualifications. Operating cash flow for the half year turned negative at ₹(32.85) lakhs, mainly due to a sharp increase in loans given and working capital outflows, though investing activities brought in ₹21 lakhs from matured fixed deposits.
Mixed picture for shareholders — profitability improved in Q2 but revenue is shrinking and the company is burning cash from operations, which raises questions about working capital and loan-recovery risk. Short-term stock reaction may be muted; investors should watch whether revenue stabilises and operating cash flow turns positive in H2.